Clinical Trials · NCT01070758
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Sheba Medical Center
- Enrollment
- 3
- Start date
- Feb 2010
- Locations
- 1 site, Israel
- Primary endpoint
- Euglycemia as recorded by Continuous Glucose Monitoring System (CGMS)